70 results
Page 2 of 4
8-K
EX-10.1
1nkcv9gu 91cgtfv2b
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
8-K
EX-10.4
8mpy3
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm
424B5
bar6c5wn
14 Jul 21
Prospectus supplement for primary offering
4:16pm
8-K
EX-1.1
kysj92g s62k2a8wb7u7
14 Jul 21
Imara Announces Launch of Proposed Public Offering
9:19am
424B5
yh290c8 udhuzhqulb4
13 Jul 21
Prospectus supplement for primary offering
4:20pm
8-K
EX-99.1
q262rrcjab 6erb
13 Jul 21
Other Events
4:07pm
DEF 14A
t4ysz3c adh4
18 May 21
Definitive proxy
4:06pm
10-K
l6z bzgxmvrxvqojh2o6
5 Mar 21
Annual report
7:26am
8-K
7at8nb
23 Apr 20
Industry leader with global clinical development expertise to help guide Imara’s clinical advancement
7:15am
8-K
EX-3.1
e5nrh5yx0
16 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
EX-3.2
idyj2yj6ws7i06cgjlze
16 Mar 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
424B4
r2i185g5 n9m482a2rpa
12 Mar 20
Prospectus supplement with pricing info
4:03pm
S-1/A
0jw ek4qgb
3 Mar 20
IPO registration (amended)
6:13am
S-1/A
EX-10.6
qpokd
3 Mar 20
IPO registration (amended)
6:13am